Showing results (1-10 of 469) with videos related to
Sort By:
Pageof 47
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Emerging Therapies for Inflammatory Bowel DiseasesReena Khanna, Brian G FeaganImmunotherapy|August 2, 2013
Ustekinumab for the treatment of Crohn's diseaseReena Khanna, Brian G FeaganExpert Opinion on Drug Safety|March 31, 2015
Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse eventsReena Khanna, Brian G FeaganCurrent Treatment Options in Gastroenterology|January 8, 2014
Current and Future Status of Therapeutic Drug Monitoring in the Treatment of IBDReena Khanna, Brian G FeaganGastroenterology Clinics of North America|August 26, 2017
The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better DrugsReena Khanna, Vipul Jairath, Brian G FeaganInflammatory Bowel Diseases|May 23, 2018
Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future SolutionsReena Khanna, Guangyong Zou, Brian G FeaganExpert Opinion on Investigational Drugs|July 4, 2017
Alicaforsen for the treatment of inflammatory bowel diseaseVipul Jairath, Reena Khanna, Brian G FeaganInflammatory Bowel Diseases|May 31, 2018
The Role of Biomarkers in Clinical Trials of Inflammatory Bowel DiseaseReena Khanna, Neeraj Narula, Brian G FeaganDigestive Diseases (Basel, Switzerland)|September 15, 2015
Targeting Leukocyte Trafficking in Inflammatory Bowel Disease: What Is the Clinical Evidence?Reena Khanna, Mahmoud H Mosli, Brian G FeaganDigestive Diseases (Basel, Switzerland)|March 17, 2016
Anti-Integrins in Ulcerative Colitis and Crohn's Disease: What Is Their Place?Reena Khanna, Mahmoud H Mosli, Brian G FeaganPageof 47